Form 10-Q Corbus Pharmaceuticals For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Corbus Pharma (CRBP) Tops Q3 EPS by 2c
November 11, 2015 7:33 AM ESTCorbus Pharma (NASDAQ: CRBP) reported Q3 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).
Expected Near-Term Milestones
Continue to screen and enroll patients in both the Phase 2 studies in CF and in systemic sclerosis to remain on track... MoreCorbus Pharma (CRBP) Files $100M Mixed Shelf
November 11, 2015 6:51 AM ESTCorbus Pharma (NASDAQ: CRBP) filed a registration with the U.S. SEC to sell up to $100 million of mixed securities.
... More